In India’s ever-evolving startup landscape, one thing is becoming crystal clear: ideas alone aren’t enough. Investors are now looking for proof of real innovation, and the clearest sign of that? Intellectual Property (IP) — especially patents. Gone are the days when startups could raise millions based on flashy pitches or vague promises of AI-powered disruption. […]
The rapidly evolving field of biotech patent law continues to present significant challenges, particularly when it comes to innovations involving recombinant nucleic acids and biological sequences. A recent ruling in REGENXBIO v. Sarepta Therapeutics by the US District Court for the District of Delaware has brought to light critical issues regarding patent eligibility for biotechnological
In a powerful judgment that resonates with the ongoing global debate on healthcare access versus intellectual property rights, Justice Mini Pushkarna of the Delhi High Court has delivered a standout ruling that places public health and patient affordability at the heart of India’s patent law jurisprudence. On March 24, 2025, the Court dismissed a patent
In response to President Donald Trump’s tariff policies, many countries are considering retaliation, primarily through higher tariffs and import restrictions. While these measures may impact the U.S. economy, they also pose risks for the countries imposing them. The goal is to make the pain felt in the U.S. greater than the consequences suffered by the
Ericsson and Lenovo have reached a settlement to partially resolve their ongoing patent licensing dispute, stemming from a multi-year, global patent cross-license agreement between the two companies. Under the terms of the settlement, all current lawsuits and administrative proceedings initiated by both parties across multiple jurisdictions, including those before the United States International Trade Commission
Pharmaceutical giants GSK and Pfizer have reached a settlement to resolve a long-running patent dispute related to respiratory syncytial virus (RSV) vaccines. The legal battle, which revolved around patent infringement claims, has now been brought to a close through an agreement between the two companies. The lawsuit centered on allegations that Pfizer’s RSV vaccine infringed
In today’s globalized marketplace, intellectual property (IP) law plays a critical role in protecting the rights of creators, innovators, and businesses. Two common forms of IP protection that frequently intersect are plant variety denominations (PVDs) and trademarks. While both legal mechanisms serve distinct purposes, the conflict between them has become increasingly relevant in agricultural and
In a landmark decision, the U.S. Supreme Court has issued a unanimous ruling in Dewberry Group, Inc. v. Dewberry Engineers Inc. that underscores the importance of corporate separateness in calculating damages for trademark infringement. The Court vacated a $43 million profit disgorgement award, a ruling that has far-reaching implications for corporate liability and the recovery
In a recent global patent disputes, the Madras High Court has pronounced a ruling concerning the ongoing patent dispute in the United States involving Pfizer’s drug, VYNDAMAX (also known as TAFAMIDIS), which is used to treat a rare heart condition called transthyretin amyloid cardiomyopathy (ATTR-CM). The case is in focus due to the high stakes
First Solar an US solar panel manufacturer, has initiated legal action against JinkoSolar (Chinese solar panel manufacturer), alleging infringement of its U.S. Patent No. 9,130,074, which pertains to tunnel oxide passivated contact (TOPCon) solar technology. This patent was obtained by First Solar in 2013 through its aquiring of TetraSun, Inc. The lawsuit was filed in
